To address the problems of wind abandonment in the regional integrated energy system (RIES), which occurs when cogeneration unit operates in a heat-determined electricity operation mode, and the low efficiency of the energy storage system in a low-temperature environment, we propose an optimal scheduling method for RIES based on fine energy storage and wind power dissipation. First, a fine energy storage model is established on the source side and the conditional value at risk(CvaR) theory is used to quantify the uncertainty of wind power; then a combined heat and power demand response mechanism is introduced on the load side to reduce the peak-to-valley difference between heat and power loads, and to promote the consumption of wind power. Finally, with the objective of minimizing the total cost of RIES optimal dispatch, the example is solved on the MATLAB platform. The simulation results show that compared with the traditional model, the proposed model is not only more adaptable to the low-temperature environment, but also can effectively improve the system economy and wind power consumption.

The power generation structure and load characteristics in different provinces are quite different in China, and the distribution of peak regulating resources and demands is extremely unbalanced. Due to many factors such as low power marketization degree, shortage of peak regulating resources and block of transmission channels, the consumption of new energy is facing greater pressure. In order to improve the mutual aids in regional power grid, this paper proposes a two-layer optimization dispatching model considering the mutual aids of peak regulation resources between each province, and determines the optimal units startup mode and power output in each provinces, thus obtaining all the power supply output arrangements and the technical and economic indicators. Finally, take the actual regional power grid in China as an example, the simulation results show that the proposed model can significantly improve the new energy utilization rate, which verified the effectiveness and feasibility of the proposed model and methods in this paper.

Telecommunication infrastructure, as a technology-intensive industry, provides fundamental support for informatization construction. This paper empirically studies the impact of telecommunication infrastructure construction on economic and social innovative development using provincial panel data from China spanning from 2009 to 2022. The research findings indicate the following: (1) Telecommunication infrastructure significantly promotes innovation in terms of R&D investment, knowledge output, and application output. (2)At various stages of telecommunication technology development, the impact on innovative development varies. Iterative updates in telecommunication technology drive higher R&D expenditures, facilitating better utilization of innovation outcomes in industries. (3) There are regional disparities in the influence of telecommunication infrastructure on economic and social innovative development. In the eastern regions, telecommunication infrastructure construction primarily promotes mobile communication, with clear spillover effects. In contrast, in western regions, it mainly facilitates fixed communication networks. Therefore, in the new development stage of China, further strengthening telecommunication infrastructure construction provides a new impetus and space for economic and social innovative development. It is essential to persistently advance the coordinated construction of mobile and fixed communication infrastructure to achieve regional development coordination.

Health care in Canada is managed by provinces/territories. We investigated regional differences in survival among Canadians diagnosed with central nervous system (CNS) tumours. We identified 50,670 patients diagnosed with a first-ever primary CNS tumour between 2008 and 2017 with follow-up until December 31, 2017. We selected the four highest incidence histologies and used proportional hazards regression to estimate hazard ratios (HRs) for five regions (British Columbia, Prairie provinces, Ontario, Atlantic provinces and the Territories), adjusting for sex, tumour behaviour and patient age. Ontario had the best survival profile for all histologies investigated. The Atlantic provinces had the highest HR for glioblastoma (HR=1.26, 95% CI:1.18-1.35) and malignant glioma not otherwise specified (NOS) (Overall: HR=1.87, 95% CI:1.43-2.43; Pediatric population: HR=2.86, 95% CI:1.28-6.39). For meningioma, the Territories had the highest HR (HR=2.44, 95% CI:1.09-5.45) followed by the Prairie provinces (HR=1.52, 95% CI:1.38-1.67). For malignant unclassified tumours, the highest HRs were in British Columbia (HR=1.45, 95% CI:1.22-1.71) and the Atlantic provinces (HR=1.40, 95% CI:1.13-1.74). There are regional differences in the survival of CNS patients at the population level for all four specific histological types of CNS tumours investigated. Factors contributing to these observed regional survival differences are unknown and warrant further investigation.

Background: The accurate diagnosis of regional lymph node metastasis is critical for guiding treatment decisions in head and neck cancer patients. Despite advances in imaging techniques, detecting nodal metastasis remains challenging, leading to potential undertreatment or overtreatment. This systematic review aims to identify molecular markers associated with occult metastasis in Head and Neck Squamous Cell Carcinoma (HNSCC) patients. Methods: The present research was conducted following PRISMA guidelines. Prospero registration nr. CRD42024522985. Results: Through a comprehensive literature search and review process, 634 articles were considered, 103 of them were finally included. Conclusions: Several promising markers were identified, including miR-205, DSG3, pan-CK AE1/AE3, HPV-16, Activin-A, Cyclin D1, and NPL that demonstrated effectiveness across multiple studies. Future research should focus on exploring combination scoring systems to improve diagnostic precision and optimize treatment selection in HNSCC patients.